Display options
Cite
Cao C, Ji X, Luo X, et al. Gingipains from Porphyromonas gingivalis promote the transformation and proliferation of vascular smooth muscle cell phenotypes. Int J Clin Exp Med. 2015;8(10):18327-34
Cao, C., Ji, X., Luo, X., & Zhong, L. (2015). Gingipains from Porphyromonas gingivalis promote the transformation and proliferation of vascular smooth muscle cell phenotypes. International journal of clinical and experimental medicine, 8(10), 18327-34.
Cao, Chong, et al. "Gingipains from Porphyromonas gingivalis promote the transformation and proliferation of vascular smooth muscle cell phenotypes." International journal of clinical and experimental medicine vol. 8,10 (2015): 18327-34.
Cao C, Ji X, Luo X, Zhong L. Gingipains from Porphyromonas gingivalis promote the transformation and proliferation of vascular smooth muscle cell phenotypes. Int J Clin Exp Med. 2015 Oct 15;8(10):18327-34. eCollection 2015. PMID: 26770435; PMCID: PMC4694335.
Copy Download .nbib Format: NLM
Share it on

Int J Clin Exp Med. 2015 Oct 15;8(10):18327-34. eCollection 2015.

Gingipains from Porphyromonas gingivalis promote the transformation and proliferation of vascular smooth muscle cell phenotypes.

International journal of clinical and experimental medicine

Chong Cao, Xiaowei Ji, Xin Luo, Liangjun Zhong

Affiliations

  1. Department of Periodontology, The First Affiliated Hospital of Xinjiang Medical University Urumqi 830054, China.
  2. Department of Prosthodontics, The First Affiliated Hospital of Xinjiang Medical University Urumqi 830054, China.
  3. Department of Pharmacology, The Basic Medical Sciences College of Xinjiang Medical University Urumqi 830054, China.
  4. Department of Periodontology, The First Affiliated Hospital of Xinjiang Medical UniversityUrumqi 830054, China; Medical College of Hangzhou Normal UniversityHangzhou 311121, China; Department of Stomatology, The Affiliated Hospital of Hangzhou Normal UniversityHangzhou 310015, China.

PMID: 26770435 PMCID: PMC4694335

Abstract

The aim of the present study was to ascertain the effect of Porphyromonas gingivalis cysteine protease gingipain on the proliferation of rat aortic smooth muscle cells (RASMCs). Gingipains were isolated and purified from the supernatant of P. gingivalis W83, which was cultured under standard anaerobic conditions; primary RASMCs were also cultured. RASMCs were exposed to 200, 100, 50, 25, 12, 6, 3, 1, and 0 μg/mL activated gingipains and the proliferation was evaluated using a cell counting kit-8 (CCK-8) assay after 48 h. α-Smooth muscle actin (α-SMA) and osteopontin (OPN) expression were measured by immunohistochemical staining. In addition, RASMCs were stimulated with 5, 10, 20, and 40 μM KYT-1 (arg-gingipain inhibitor) and KYT-36 (lys-gingipain inhibitor) in combination with the gingipain extracts. Different concentrations of gingipains significantly promoted the proliferation of RASMCs, except those treated with 1 μg/mL, compared to the untreated controls. The proliferation was sustained at a concentration above 12 μg/mL. Immunohistochemical staining showed OPN expression after gingipain stimulation. The proliferative effects of gingipains on RASMCs were blocked after treatment with 10 μM KYT-1 or 10 μM KYT-36 (P < 0.0001); however, the difference between KYT-1 and KYT-36 groups was not statistically significant. These results demonstrated that gingipains can promote phenotypic transformation and proliferation of RASMCs and their effects were blocked by KYT-1 and KYT-36, which help us to ascertain whether Rgp or Kgp contributes to the development of atherosclerosis.

Keywords: Gingipains; phenotype transformation; proliferation; smooth muscle cell

References

  1. Oral Microbiol Immunol. 2005 Oct;20(5):296-302 - PubMed
  2. FEBS Lett. 2009 Jan 5;583(1):128-34 - PubMed
  3. Arch Med Res. 2015 Feb;46(2):112-7 - PubMed
  4. Physiology (Bethesda). 2009 Feb;24:36-44 - PubMed
  5. J Biochem. 2006 Nov;140(5):713-23 - PubMed
  6. Int J Mol Med. 2014 May;33(5):1341-7 - PubMed
  7. Future Microbiol. 2009 May;4(4):471-87 - PubMed
  8. Immunopharmacol Immunotoxicol. 2012 Jun;34(3):470-6 - PubMed
  9. J Periodontol. 2011 Nov;82(11):1616-22 - PubMed
  10. Curr Protein Pept Sci. 2003 Dec;4(6):409-26 - PubMed
  11. Atherosclerosis. 2014 Oct;236(2):327-37 - PubMed
  12. Toxins (Basel). 2010 Mar;2(3):341-52 - PubMed
  13. Mol Pharmacol. 2004 Dec;66(6):1599-606 - PubMed
  14. Mol Cell Biochem. 2013 May;377(1-2):1-10 - PubMed
  15. BMC Genomics. 2013 Nov 09;14:770 - PubMed
  16. Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2370-7 - PubMed
  17. Cell Microbiol. 2012 Jul;14(7):1085-96 - PubMed
  18. PLoS One. 2014 May 16;9(5):e97811 - PubMed
  19. J Pharmacol Sci. 2010;113(2):115-9 - PubMed
  20. J Clin Periodontol. 2013 Oct;40(10):924-32 - PubMed
  21. Physiol Rev. 2004 Jul;84(3):767-801 - PubMed
  22. Infect Immun. 2005 Mar;73(3):1543-52 - PubMed
  23. Crit Rev Oral Biol Med. 2004 Nov 01;15(6):403-13 - PubMed
  24. Arch Oral Biol. 2011 Dec;56(12):1583-91 - PubMed
  25. J Clin Invest. 1994 Jun;93(6):2393-402 - PubMed
  26. Int J Mol Sci. 2014 Oct 17;15(10):18747-61 - PubMed
  27. J Periodontal Res. 2011 Dec;46(6):749-55 - PubMed

Publication Types